Re-vitrectomy for recurrent retinal detachment in post-vitrectomy eyes of rhegmatogenous retinal detachment.


Journal

BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802

Informations de publication

Date de publication:
16 Nov 2022
Historique:
received: 15 07 2022
accepted: 01 11 2022
entrez: 17 11 2022
pubmed: 18 11 2022
medline: 22 11 2022
Statut: epublish

Résumé

Recurrent retinal detachment (Re-RD) usually affects the prognosis of surgery for rhegmatogenous retinal detachment (RRD). Previous clinical studies of Re-RD were not specific. This study aimed to analyze the clinical characteristics of Re-RD in post-vitrectomy eyes with RRD and surgical outcomes after revitrectomy without combining it with retinectomy or scleral buckling. This is a retrospective case series analyzed the ocular characteristics of 20 recurrent and contralateral eyes, evaluated the significance of the associations between variables before reoperation and the final best-corrected visual acuity (BCVA), and calculated the outcome of revitrectomy. Patients with phakic eyes, those undergoing only one surgery, and those with more than one break had better final BCVA. The final BCVA was negatively correlated with the axial length and positively correlated with the preoperative BCVA. Among the 12 eyes with no break detected before surgery, 11 (92%) were found to have a small crevice-like break beside the pigment scar of a large number of original laser spots. The single-operation complete retinal reattachment rate was 75%, the complete retinal reattachment rate was 80%, and the final incomplete retinal reattachment rate was 90%. The BCVA improved from 1.2 ± 0.6LogMAR (0.06 ± 0.25) before surgery to 0.8 ± 0.7LogMAR (0.15 ± 0.2) at the last follow-up. The BCVA of 16 patients with complete retinal reattachment improved from 1.0 ± 0.5LogMAR (0.1 ± 0.3) to 0.6 ± 0.4LogMAR (0.25 ± 0.4). In the contralateral eyes, 15% already had vision-damaging disease, and the incidence of eyesight-threating lesions was 5.9% during follow-up. Revitrectomy without retinectomy or scleral buckling can effectively treat Re-RD in post-vitrectomy eyes. In Re-RD patients with no definite retinal break detected preoperatively, the retinal hole usually shows small crevice-like changes alongside a large number of original laser pigment scars.

Sections du résumé

BACKGROUND BACKGROUND
Recurrent retinal detachment (Re-RD) usually affects the prognosis of surgery for rhegmatogenous retinal detachment (RRD). Previous clinical studies of Re-RD were not specific. This study aimed to analyze the clinical characteristics of Re-RD in post-vitrectomy eyes with RRD and surgical outcomes after revitrectomy without combining it with retinectomy or scleral buckling.
METHODS METHODS
This is a retrospective case series analyzed the ocular characteristics of 20 recurrent and contralateral eyes, evaluated the significance of the associations between variables before reoperation and the final best-corrected visual acuity (BCVA), and calculated the outcome of revitrectomy.
RESULTS RESULTS
Patients with phakic eyes, those undergoing only one surgery, and those with more than one break had better final BCVA. The final BCVA was negatively correlated with the axial length and positively correlated with the preoperative BCVA. Among the 12 eyes with no break detected before surgery, 11 (92%) were found to have a small crevice-like break beside the pigment scar of a large number of original laser spots. The single-operation complete retinal reattachment rate was 75%, the complete retinal reattachment rate was 80%, and the final incomplete retinal reattachment rate was 90%. The BCVA improved from 1.2 ± 0.6LogMAR (0.06 ± 0.25) before surgery to 0.8 ± 0.7LogMAR (0.15 ± 0.2) at the last follow-up. The BCVA of 16 patients with complete retinal reattachment improved from 1.0 ± 0.5LogMAR (0.1 ± 0.3) to 0.6 ± 0.4LogMAR (0.25 ± 0.4). In the contralateral eyes, 15% already had vision-damaging disease, and the incidence of eyesight-threating lesions was 5.9% during follow-up.
CONCLUSIONS CONCLUSIONS
Revitrectomy without retinectomy or scleral buckling can effectively treat Re-RD in post-vitrectomy eyes. In Re-RD patients with no definite retinal break detected preoperatively, the retinal hole usually shows small crevice-like changes alongside a large number of original laser pigment scars.

Identifiants

pubmed: 36384489
doi: 10.1186/s12886-022-02665-8
pii: 10.1186/s12886-022-02665-8
pmc: PMC9670523
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

439

Informations de copyright

© 2022. The Author(s).

Références

Am J Ophthalmol. 1988 Nov 15;106(5):519-32
pubmed: 3056014
Semin Ophthalmol. 2018;33(5):657-663
pubmed: 29125779
Br J Ophthalmol. 2001 Oct;85(10):1203-7
pubmed: 11567965
Indian J Ophthalmol. 2012 Nov-Dec;60(6):517-20
pubmed: 23202389
Eur J Ophthalmol. 2022 May;32(3):1728-1734
pubmed: 34109851
Retina. 2012 Nov-Dec;32(10):2034-8
pubmed: 22653544
Acta Ophthalmol. 2016 Nov;94(7):e624-e628
pubmed: 27061348
Int J Ophthalmol. 2019 Apr 18;12(4):615-620
pubmed: 31024816
Int Ophthalmol. 2014 Jun;34(3):549-56
pubmed: 24092458
Graefes Arch Clin Exp Ophthalmol. 2021 Feb;259(2):335-341
pubmed: 32926193
Semin Ophthalmol. 2018;33(1):70-74
pubmed: 29185844
Surv Ophthalmol. 1998 Jul-Aug;43(1):3-18
pubmed: 9716190
Retina. 2020 May;40(5):805-810
pubmed: 30845028
Eye (Lond). 2000 Dec;14(Pt 6):834-8
pubmed: 11584838
Retina. 2017 May;37(5):930-935
pubmed: 27635776
Am J Ophthalmol. 1986 Aug 15;102(2):276-8
pubmed: 3740192
Ophthalmology. 2002 Oct;109(10):1821-7
pubmed: 12359601
Can J Ophthalmol. 2016 Oct;51(5):331-335
pubmed: 27769322
Int J Ophthalmol. 2021 Dec 18;14(12):1909-1914
pubmed: 34926207
Ophthalmic Surg Lasers Imaging Retina. 2014 Sep-Oct;45(5):409-13
pubmed: 25291784
Retina. 2000;20(3):257-61
pubmed: 10872930
Ophthalmology. 2006 Mar;113(3):398-403
pubmed: 16406538
Ophthalmology. 2016 May;123(5):1137-42
pubmed: 26952593
J Ophthalmol. 2020 Dec 17;2020:6637143
pubmed: 33489337
Retina. 2011 Sep;31(8):1500-4
pubmed: 21606887
J Fr Ophtalmol. 2019 Nov;42(9):974-982
pubmed: 31230896
Ophthalmology. 1996 Jul;103(7):1092-9
pubmed: 8684799
Semin Ophthalmol. 2014 Sep-Nov;29(5-6):312-8
pubmed: 25325856
Retina. 1989;9(3):181-6
pubmed: 2595109
Retina. 2014 Apr;34(4):684-92
pubmed: 24169100
Ophthalmology. 1998 May;105(5):785-8
pubmed: 9593376
Graefes Arch Clin Exp Ophthalmol. 1996 Dec;234(12):739-43
pubmed: 8986445
ScientificWorldJournal. 2019 Mar 06;2019:5416806
pubmed: 30956624
Br J Ophthalmol. 2010 Oct;94(10):1344-7
pubmed: 20576784
Ophthalmic Surg. 1990 Oct;21(10):716-20
pubmed: 2250856
J Fr Ophtalmol. 2019 Feb;42(2):146-152
pubmed: 30594418
Retina. 2014 Oct;34(10):1926-38
pubmed: 24978667
Arch Ophthalmol. 1992 Jun;110(6):780-92
pubmed: 1596225
Retina. 2002 Apr;22(2):153-7
pubmed: 11927846
Graefes Arch Clin Exp Ophthalmol. 2014 Dec;252(12):1895-902
pubmed: 25377435
Int Ophthalmol Clin. 2019 Winter;59(1):221-240
pubmed: 30585928
Ophthalmic Surg Lasers Imaging Retina. 2019 Nov 1;50(11):e278-e287
pubmed: 31755979
BMC Ophthalmol. 2015 Dec 09;15:173
pubmed: 26645589
Acta Ophthalmol Scand. 2000 Apr;78(2):182-6
pubmed: 10794253
Ophthalmic Surg Lasers Imaging Retina. 2021 Mar;52(3):138-144
pubmed: 34038688
Ophthalmology. 2006 Nov;113(11):2041-7
pubmed: 16952397
Asia Pac J Ophthalmol (Phila). 2016 Nov/Dec;5(6):394-402
pubmed: 27898442

Auteurs

Jun-Xing Bai (JX)

Beijing Ophthalmolgy and Visual Science Key Laboratory, Department of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, No.1 Dongjiaomin Alley, Dongcheng District, Beijing, 100730, People's Republic of China.
Department of Ophthalmology, Beijing Hua-Er Hospital, No.59 Xizongbu Lane,Dongcheng District, Beijing, 100005, People's Republic of China.

Wei-Yu Zheng (WY)

Department of Ophthalmology, Beijing Meiermu Hospital, No.65 Fuxing Road, Haidian District, Beijing, 100036, People's Republic of China.

Xiao-Qing Zhu (XQ)

Beijing Ophthalmolgy and Visual Science Key Laboratory, Department of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, No.1 Dongjiaomin Alley, Dongcheng District, Beijing, 100730, People's Republic of China. zhuxiaoqing2022@mail.ccmu.edu.cn.

Xiao-Yan Peng (XY)

Beijing Ophthalmolgy and Visual Science Key Laboratory, Department of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, No.1 Dongjiaomin Alley, Dongcheng District, Beijing, 100730, People's Republic of China. 74000041@ccmu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH